InvestorsObserver
Sign Up Login

NHS Neuberger Berman High Yield Stra

$7.72 $0.00 (0.00%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

NHS Stock Analysis Overview

What this means: Neuberger Berman High Yield Stra (NHS) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives NHS a rank of 12. Our methodology considers analysis of the company's financial situation and how it has traded recently. NHS rank of 12 means that it ranks below 88% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

NHS Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

NHS Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

NHS Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

NHS Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

NHS Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

NHS Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

NHS Stock Analysis Overview

What this means: Neuberger Berman High Yield Stra (NHS) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives NHS a rank of 12. Our methodology considers analysis of the company's financial situation and how it has traded recently. NHS rank of 12 means that it ranks below 88% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full NHS report

NHS Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

NHS Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

NHS Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

NHS Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

NHS Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

NHS Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Neuberger Berman High Yield Stra (NHS) Analyst Forecast

NHS Price, Volume, Earnings, and Dividend Date

  • Last Price $7.72
  • Previous Close $7.72
  • Change $0.00
  • Open $7.76
  • Volume 244,291
  • Avg. Volume (100-day) 129,275
  • Market Cap 150,058,897
  • Days Range 7.68 - 7.77
  • 52-week Range 6.95 - 9.4
  • Dividend Yield 14.07%
  • Ex. Dividend Date 12/14/23
  • P-E —
  • EPS —
  • Earnings Date —
  • Sector Financial Services
  • Industry Asset Management
  • Avg. Analyst Rec. Premium
  • Beta 0.757
  • PEG Ratio —

Neuberger Berman High Yield Stra (NHS) Company Description

The Fund will invest at least 80% of its managed assets in below investment grade (high yield) debt securities of U.

Neuberger Berman High Yield Stra (NHS) Stock Chart

View Interactive NHS chart

My Watchlists

Top Stocks in Asset Management